Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Multiple Myeloma × venetoclax × Clear all

Phase

Status

Sponsor Class

INDUSTRY 15 OTHER 7 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Burkitt Lymphoma 1

Interventions

Dexamethasone 41 Bortezomib 20 Cyclophosphamide 18 Lenalidomide 17 daratumumab 14 Calcium Dobesilate 12 Thalidomide 11 Melphalan 11 carfilzomib 7 Prednisone 7 Peripheral Blood Stem Cell Transplantation 6 Doxorubicin 6 pomalidomide 5 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Vincristine 4 Filgrastim 4 Interferon-alpha 3 selinexor 2 sargramostim 2 ixazomib 2 isatuximab 2 elotuzumab 2 cobimetinib 2 Steroids 2 Radiotherapy 2 Microarray Analysis 2 Gene Expression Profiling 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡